ImmunoPrecise Antibodies Statistics
Total Valuation
IPA has a market cap or net worth of $17.28 million. The enterprise value is $17.95 million.
Important Dates
The last earnings date was Friday, March 28, 2025, before market open.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IPA has 45.77 million shares outstanding. The number of shares has increased by 13.69% in one year.
| Current Share Class | 45.77M |
| Shares Outstanding | 45.77M |
| Shares Change (YoY) | +13.69% |
| Shares Change (QoQ) | +16.78% |
| Owned by Insiders (%) | 9.17% |
| Owned by Institutions (%) | 4.17% |
| Float | 41.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| Forward PS | 0.70 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.51.
| Current Ratio | 2.32 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.66 |
Financial Efficiency
Return on equity (ROE) is -124.75% and return on invested capital (ROIC) is -18.07%.
| Return on Equity (ROE) | -124.75% |
| Return on Assets (ROA) | -14.88% |
| Return on Invested Capital (ROIC) | -18.07% |
| Return on Capital Employed (ROCE) | -40.39% |
| Revenue Per Employee | $164,169 |
| Profits Per Employee | -$319,781 |
| Employee Count | 101 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 5.30 |
Taxes
| Income Tax | -3.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.05% in the last 52 weeks. The beta is 0.35, so IPA's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -75.05% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 43.86 |
| Average Volume (20 Days) | 2,355,839 |
Short Selling Information
The latest short interest is 3.03 million, so 6.63% of the outstanding shares have been sold short.
| Short Interest | 3.03M |
| Short Previous Month | 2.19M |
| Short % of Shares Out | 6.63% |
| Short % of Float | 7.30% |
| Short Ratio (days to cover) | 0.64 |
Income Statement
In the last 12 months, IPA had revenue of $16.58 million and -$32.30 million in losses. Loss per share was -$1.13.
| Revenue | 16.58M |
| Gross Profit | 8.43M |
| Operating Income | -10.21M |
| Pretax Income | -20.89M |
| Net Income | -32.30M |
| EBITDA | -7.61M |
| EBIT | -10.21M |
| Loss Per Share | -$1.13 |
Full Income StatementBalance Sheet
The company has $8.92 million in cash and $8.93 million in debt, giving a net cash position of -$8,982 or -$0.00 per share.
| Cash & Cash Equivalents | 8.92M |
| Total Debt | 8.93M |
| Net Cash | -8,982 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | 17.36M |
| Book Value Per Share | 0.53 |
| Working Capital | 8.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.47 million and capital expenditures -$1.08 million, giving a free cash flow of -$6.61 million.
| Operating Cash Flow | -5.47M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -6.61M |
| FCF Per Share | -$0.14 |
Full Cash Flow StatementMargins
Gross margin is 50.82%, with operating and profit margins of -61.61% and -194.79%.
| Gross Margin | 50.82% |
| Operating Margin | -61.61% |
| Pretax Margin | -213.31% |
| Profit Margin | -194.79% |
| EBITDA Margin | -45.89% |
| EBIT Margin | -61.61% |
| FCF Margin | n/a |
Dividends & Yields
IPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.69% |
| Shareholder Yield | n/a |
| Earnings Yield | -180.03% |
| FCF Yield | -36.82% |
Analyst Forecast
The average price target for IPA is $4.00, which is 959.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 959.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 15.97% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 23, 2020. It was a reverse split with a ratio of 0.2:1.
| Last Split Date | Nov 23, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |